Evaluation of the efficacy, acceptability and palatability of calcium montmorillonite clay used to reduce aflatoxin B1 dietary exposure in a crossover study in Kenya

References

• Afriyie-Gyawu E, Ankrah NA, Huebner HJ, Ofosuhene M, Kumi J, Johnson NM, Tang L, Xu L, Jolly PE, Ellis WO, et al. 2008. NovaSil clay intervention in Ghanaians at high risk for aflatoxicosis. I. Study design and clinical outcomes. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 25:76–87.
   PubMed Web of Science ®Google Scholar
• Afriyie-Gyawu E, Mackie J, Dash B, Wiles M, Taylor J, Huebner H, Tang L, Guan H, Wang JS, Phillips T. 2005. Chronic toxicological evaluation of dietary NovaSil clay in Sprague-Dawley rats. Food Addit Contam. 22:259–269.
   PubMed Web of Science ®Google Scholar
• Afriyie-Gyawu E, Wang Z, Ankrah NA, Xu L, Johnson NM, Tang L, Guan H, Huebner HJ, Jolly PE, Ellis WO, et al. 2008. NovaSil clay does not affect the concentrations of vitamins A and E and nutrient minerals in serum samples from Ghanaians at high risk for aflatoxicosis. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 25:872–884.
   PubMed Web of Science ®Google Scholar
• Azziz-Baumgartner E, Lindblade K, Gieseker K, Rogers HS, Kieszak S, Njapau H, Schleicher R, McCoy LF, Misore A, DeCock K, et al. 2005. Case-control study of an acute aflatoxicosis outbreak, Kenya, 2004. Environ Health Perspect. 113:1779–1783.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC). 2004. Outbreak of aflatoxin poisoning–eastern and central provinces, Kenya, January-July 2004. MMWR Morb Mortal Wkly Rep. 53:790–793.
   PubMedGoogle Scholar
• Cotty PJ, Antilla L, Wakelyn PJ. 2007. Competitive exclusion of aflatoxin producers: farmer driven research and development. In: Vincent C, Goettel N, Lazarovitis G, editors. Biological control: a global perspective. Oxfordshire: CAB International; p. 241–253.
   Google Scholar
• Grant PG, Phillips TD. 1998. Isothermal adsorption of Aflatoxin B(1) on HSCAS Clay. J Agric Food Chem. 46:599–605.
   PubMed Web of Science ®Google Scholar
• Groopman JD, Hasler JA, Trudel LJ, Pikul A, Donahue PR, Wogan GN. 1992. Molecular dosimetry in rat urine of aflatoxin-N7-guanine and other aflatoxin metabolites by multiple monoclonal antibody affinity chromatography and immunoaffinity/high performance liquid chromatography. Cancer Res. 52:267–274.
   PubMed Web of Science ®Google Scholar
• Harvey RB, Kubena LF, Elissalde MH, Phillips TD. 1993. Efficacy of zeolitic ore compounds on the toxicity of aflatoxin to growing broiler chickens. Avian Dis. 37:67–73.
   PubMed Web of Science ®Google Scholar
• Harvey RB, Phillips TD, Ellis JA, Kubena LF, Huff WE, Petersen HD. 1991. Effects on aflatoxin M1 residues in milk by addition of hydrated sodium calcium aluminosilicate to aflatoxin-contaminated diets of dairy cows. Am J Vet Res. 52:1556–1559.
   PubMed Web of Science ®Google Scholar
• Hell K, Fandohan P, Bandyopadhyay R, Kiewnick S, Sikora R, Cotty PJ. 2008. Pre- and post-harvest management of aflatoxin in maize: an African perspective. In: Leslie J, Bandyopadhyay R, Visconti A, editors. Mycotoxins: detection methods, management, public health, and agricultural trade. Oxfordshire: CAB International; p. 219–229.
   Google Scholar
• Marroquín-Cardona A, Deng Y, Garcia-Mazcorro J, Johnson NM, Mitchell N, Tang L, Robinson A 2nd, Taylor J, Wang JS, Phillips TD. 2011. Characterization and safety of uniform particle size NovaSil clay as a potential aflatoxin enterosorbent. Appl Clay Sci. 54:248–257.
   PubMed Web of Science ®Google Scholar
• Mayura K, Abdel-Wahhab MA, McKenzie KS, Sarr AB, Edwards JF, Naguib K, Phillips TD. 1998. Prevention of maternal and developmental toxicity in rats via dietary inclusion of common aflatoxin sorbents: potential for hidden risks. Toxicol Sci. 41:175–182.
   PubMed Web of Science ®Google Scholar
• McCoy LF, Scholl PF, Schleicher RL, Groopman JD, Powers CD, Pfeiffer CM. 2005. Analysis of aflatoxin B1-lysine adduct in serum using isotope-dilution liquid chromatography/tandem mass spectrometry. Rapid Commun Mass Spectrom. 19:2203–2210.
   PubMed Web of Science ®Google Scholar
• Mitchell NJ, Kumi J, Aleser M, Elmore SE, Rychlik KA, Zychowski KE, Romoser AA, Phillips TD, Ankrah NA. 2014. Short-term safety and efficacy of calcium montmorillonite clay (UPSN) in children. Am J Trop Med Hyg. 91:777–785.
   PubMed Web of Science ®Google Scholar
• Mitchell NJ, Kumi J, Johnson NM, Dotse E, Marroquin-Cardona A, Wang J-S, Jolly PE, Ankrah N-A, Phillips TD. 2013. Reduction in the urinary aflatoxin M1 biomarker as an early indicator of the efficacy of dietary interventions to reduce exposure to aflatoxins. Biomarkers. 18:391–398.
   PubMed Web of Science ®Google Scholar
• Ngindu A, Johnson BK, Kenya PR, Ngira JA, Ocheng DM, Nandwa H, Omondi TN, Jansen AJ, Ngare W, Kaviti JN, Gatei D, Siongok TA. 1982. Outbreak of acute hepatitis caused by aflatoxin poisoning in Kenya. Lancet. 1:1346–8288.
   PubMed Web of Science ®Google Scholar
• Phillips TD. 1999. Dietary clay in the chemoprevention of aflatoxin-induced disease. Toxicol Sci. 52:118–126.
   PubMed Web of Science ®Google Scholar
• Phillips TD, Afriyie-Gyawu E, Williams J, Huebner H, Ankrah NA, Ofori-Adjei D, Jolly P, Johnson N, Taylor J, Marroquin-Cardona A, et al. 2008. Reducing human exposure to aflatoxin through the use of clay: a review. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 25:134–145.
   PubMed Web of Science ®Google Scholar
• Phillips TD, Kubena LF, Harvey RB, Taylor DR, Heidelbaugh ND. 1988. Hydrated sodium calcium aluminosilicate: a high affinity sorbent for aflatoxin. Poult Sci. 67:243–247.
   PubMed Web of Science ®Google Scholar
• Phillips TD, Lemke SL, Grant PG. 2002. Characterization of clay-based enterosorbents for the prevention of aflatoxicosis. Adv Exp Med Biol. 504:157–171.
   PubMed Web of Science ®Google Scholar
• Phillips TD, Sarr AB, Grant PG. 1995. Selective chemisorption and detoxification of aflatoxins by phyllosilicate clay. Nat Toxins. 3:204-213; discussion 221.
   PubMedGoogle Scholar
• Pollock BH, Elmore S, Romoser A, Tang L, Kang M, Xue K, Rodriguez M, Dierschke NA, Hayes HG, Hansen HA, et al. 2016. Intervention trial with calcium montmorillonite clay in a south Texas population exposed to aflatoxin. Food Addit Contam Part A. 1–9. doi:10.1080/19440049.2016.1198498
   Google Scholar
• Sarr AB, Mayura K, Kubena LF, Harvey RB, Phillips TD. 1995. Effects of phyllosilicate clay on the metabolic profile of aflatoxin B1 in Fischer-344 rats. Toxicol Lett. 75:145–151.
   PubMed Web of Science ®Google Scholar
• Turner PC, Sylla A, Gong YY, Diallo MS, Sutcliffe AE, Hall AJ, Wild CP. 2005. Reduction in exposure to carcinogenic aflatoxins by postharvest intervention measures in west Africa: a community-based intervention study. Lancet. 365:1950–1956.
   PubMed Web of Science ®Google Scholar
• US Federal Drug Agency Title 21. Substances generally recognized as safe, 21CFR582. Code of Federal Regulations. United States Government Printing Office. Available from: https://www.gpo.gov/fdsys/pkg/CFR-2012-title21-vol6/pdf/CFR-2012-title21-vol6-part582.pdf
   Google Scholar
• Wang EA. 2008. Novasil Clay intervention in Ghanians at high risk for aflatoxicosis: 11 Reduction in biomarkkers of aflatoxin exposure in blood and urine. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 25:622–634.
   PubMed Web of Science ®Google Scholar
• Wang JS, Luo H, Billam M, Wang Z, Guan H, Tang L, Goldston T, Afriyie-Gyawu E, Lovett C, Griswold J, et al. 2005. Short-term safety evaluation of processed calcium montmorillonite clay (NovaSil) in humans. Food Addit Contam. 22:270–279.
   PubMed Web of Science ®Google Scholar
• Wang JS, Shen X, He X, Zhu YR, Zhang BC, Wang JB, Qian GS, Kuang SY, Zarba A, Egner PA, et al. 1999. Protective alterations in phase 1 and 2 metabolism of aflatoxin B1 by oltipraz in residents of Qidong, people’s republic of China. J Natl Cancer Inst. 91:347–354.
   PubMed Web of Science ®Google Scholar
• Wang P, Afriyie-Gyawu E, Tang Y, Johnson NM, Xu L, Tang L, Huebner HJ, Ankrah NA, Ofori-Adjei D, Ellis W, et al. 2008. NovaSil clay intervention in Ghanaians at high risk for aflatoxicosis: II. Reduction in biomarkers of aflatoxin exposure in blood and urine. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 25:622–634.
   PubMed Web of Science ®Google Scholar
• Warth B, Sulyok M, Fruhmann P, Mikula H, Berthiller F, Schuhmacher R, Hametner C, Abia WA, Adam G, Frohlich J, Krska R. 2012. Development and validation of a rapid multi-biomarker liquid chromatography/tandem mass spectrometry method to assess human exposure to mycotoxins. Rapid Commun Mass Spectrom. 26:1533–1540.
   PubMed Web of Science ®Google Scholar
• Wild CP, Gong YY. 2010. Mycotoxins and human disease: a largely ignored global health issue. Carcinogenesis. 31:71–82.
   PubMed Web of Science ®Google Scholar
• Wild C. 2010. Mycotoxins and human disease: a largely ignored global health issue. Carcinogenesis. 31:71–82.
   PubMed Web of Science ®Google Scholar
• Williams JH, Phillips TD, Jolly PE, Stiles JK, Jolly CM, Aggarwal D. 2004. Human aflatoxicosis in developing countries: a review of toxicology, exposure, potential health cosequences and interventions. Am J Nutritio. 80:1106–1122.
   PubMed Web of Science ®Google Scholar
• Wu F, Mitchell NJ, Male D, Kensler TW. 2014. Reduced foodborne toxin exposure is a benefit of improving dietary diversity. Toxicol Sci. 141:329–334.
   PubMed Web of Science ®Google Scholar
• Yard EE, Daniel JH, Lewis LS, Rybak ME, Paliakov EM, Kim AA, Montgomery JM, Bunnell R, Abudo MU, Akhwale W, et al. 2013. Human aflatoxin exposure in Kenya, 2007: a cross-sectional study. Food Addit Contam Part A Chem Anal Control Expo Risk Assess. 30:1322–1331.
   PubMed Web of Science ®Google Scholar
• Yin Y-N, Yan L-Y, Jiang J-H, Ma Z-H. 2008. Biological control of aflatoxin contamination of crops. J Zhejiang Univ Sci B. 9:787–792.
   PubMed Web of Science ®Google Scholar